Introduction of antisense CD44S CDNA down-regulates expression of overall CD44 isoforms and inhibits tumor growth and metastasis in highly metastatic colon carcinoma cells.
about
Podocalyxin-like protein is an E-/L-selectin ligand on colon carcinoma cells: comparative biochemical properties of selectin ligands in host and tumor cellsBiomolecular characterization of CD44-fibrin(ogen) binding: distinct molecular requirements mediate binding of standard and variant isoforms of CD44 to immobilized fibrin(ogen)Adhesion molecules in peritoneal dissemination: function, prognostic relevance and therapeutic optionsAn Omics Perspective on Molecular Biomarkers for Diagnosis, Prognosis, and Therapeutics of CholangiocarcinomaCancer stem cells in colorectal cancer from pathogenesis to therapy: controversies and perspectivesPathophysiology of colorectal peritoneal carcinomatosis: Role of the peritoneumHyaluronan - a functional and structural sweet spot in the tissue microenvironmentThe dual role of CD44 as a functional P-selectin ligand and fibrin receptor in colon carcinoma cell adhesionStrategies to prevent peritoneal carcinomatosis arising from colorectal cancer.Stable alterations of CD44 isoform expression in prostate cancer cells decrease invasion and growth and alter ligand binding and chemosensitivity.Genome-wide expression patterns associated with oncogenesis and sarcomatous transdifferentation of cholangiocarcinoma.Osteopontin facilitates ultraviolet B-induced squamous cell carcinoma development.Apc(MIN) modulation of vitamin D secosteroid growth controlLymphangioleiomyomatosis (LAM): molecular insights lead to targeted therapies.High adhesion of tumor cells to mesothelial monolayers derived from peritoneal wash of disseminated gastrointestinal cancers.Silibinin suppresses CD44 expression in prostate cancer cellsCD44 expression in intestinal epithelium and colorectal cancer is independent of p53 statusDocosahexaenoic acid (DHA) sensitizes brain tumor cells to etoposide-induced apoptosisInteractions between colon cancer cells and hepatocytes in rats in relation to metastasisDivergent roles of CD44 and carcinoembryonic antigen in colon cancer metastasis.Osteopontin increases hepatocellular carcinoma cell growth in a CD44 dependant manner.CD44 enhances tumor aggressiveness by promoting tumor cell plasticity.Levels of v5 and v6 CD44 splice variants in serum of patients with colorectal cancer are not correlated with pT stage, histopathological grade of malignancy and clinical features.Altered tumor-cell glycosylation promotes metastasis.Cancer Stem Cells: A Moving TargetButyrate down-regulates CD44 transcription and liver colonisation in a highly metastatic human colon carcinoma cell line.Cross-linked hyaluronic acid sub-micron particles: in vitro and in vivo biodistribution study in cancer xenograft model.Phenyl-methylene hydantoins alter CD44-specific ligand binding of benign and malignant prostate cells and suppress CD44 isoform expression.miRNAs expressed differently in cancer stem cells and cancer cells of human gastric cancer cell line MKN-45.Identification of osteopontin as the most consistently over-expressed gene in intrahepatic cholangiocarcinoma: detection by oligonucleotide microarray and real-time PCR analysisMicroRNAs 373 and 520c are downregulated in prostate cancer, suppress CD44 translation and enhance invasion of prostate cancer cells in vitro.Cell adhesion molecule CD44: its functional roles in prostate cancer.CD44s expression in resectable colorectal carcinomas and surrounding mucosa.
P2860
Q24653465-86DEEC1E-A703-4712-AC7D-8FB56153EC5AQ24654120-7E8240CD-6D86-4EED-B237-B612FC99F787Q26748666-9C555868-D331-4F68-AF83-8CB6CD232175Q26784091-DF4809F9-71D1-4FE0-825F-6E69F6CB7F1FQ27024651-EC7A7A2E-FC10-46B3-A42F-7235FF3DB26EQ28073129-724159C6-DF85-4933-B9AE-12D548BB654AQ28081088-4FE1BC0E-309A-4023-BD2A-90630FD16FDFQ28266614-11ED7D9C-8A58-42B4-8C05-27EDFE4CE56BQ30239825-9A38E9A5-0321-4BA9-8DBB-F7173628D025Q33523906-7C883F82-E169-442F-A561-BCC9C2660659Q33824237-CB180035-D762-48E2-A4DE-3A16DE14D8DDQ34025702-393B545B-820E-4DC1-9ABF-931C19A34AA6Q34042325-43C803E8-3BEA-444C-B4C5-3BEB02E4CB7FQ34536450-CA72F113-A0A2-4DB7-B0E8-7752EFD57D23Q34603731-BA483DE0-FA0B-4116-92E5-E8307B780FCFQ34659546-492AB237-1413-4969-84A8-CC46A767AC64Q34979644-37B49617-DCFD-4E30-A3BC-A44C7D16CC89Q35510360-5746B52A-4685-48F5-8A10-B70A1C9F1AE7Q35862502-448B2240-8B15-4AE1-AB19-D3E982608877Q35987882-83CCCA12-4B78-4D43-9C25-21CCC1F7A521Q36093343-D267A8D9-6F36-4E2E-B38D-6ADB5C90FE3EQ36260608-5C84B463-F98F-4442-8016-71275FCB15D3Q36474315-D0FB6C19-8F39-4EB7-BB31-3734095AA617Q37581540-4FB83214-886F-4488-9186-1686BF0641C6Q38126498-80651D10-4EED-4520-B485-4E009EC6E3A5Q38360807-B93B03F8-D434-4C05-B002-DC015E17FA98Q39183455-0745D603-2B46-45DB-BB0D-C11EBDBF70F5Q39208225-32B37766-61FB-4581-992C-0A5CCAFAA5B6Q39388462-CF92F081-9B9C-4EA4-8AFF-DC6B055F500AQ42003931-59616311-7F7E-41CE-8A61-83A303CB508FQ42147457-A8B0F03C-DB16-4E6F-9EEF-54F7CB30C27CQ42363361-293E5BC8-7A29-4C1D-847E-E1D71DCE25A3Q45217747-22953818-9A1C-4AAD-9F02-EF4AF6C2188F
P2860
Introduction of antisense CD44S CDNA down-regulates expression of overall CD44 isoforms and inhibits tumor growth and metastasis in highly metastatic colon carcinoma cells.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Introduction of antisense CD44 ...... astatic colon carcinoma cells.
@en
type
label
Introduction of antisense CD44 ...... astatic colon carcinoma cells.
@en
prefLabel
Introduction of antisense CD44 ...... astatic colon carcinoma cells.
@en
P2093
P2860
P1476
Introduction of antisense CD44 ...... astatic colon carcinoma cells.
@en
P2093
M Kinouchi
P2860
P356
10.1002/1097-0215(20010101)91:1<67::AID-IJC1011>3.0.CO;2-D
P577
2001-01-01T00:00:00Z